Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

• Autors principals: Hamdy SM (Autor), Abdel-Naseer M (Autor), Shehata HS (Autor), Hassan A (Autor), Elmazny A (Autor), Shalaby NM (Autor), Abokrysha NT (Autor), Kishk NA (Autor), Nada MAF (Autor), Ahmed SM (Autor), Hegazy MI (Autor), Mekkawy D (Autor), Mourad HS (Autor), Abdelalim A (Autor), Berger T (Autor)
• Format: Llibre
• Publicat: Dove Medical Press, 2020-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...